When looking for a CDMO to develop and manufacture HPAPIs, innovators need a partner with sufficient technical acumen, containment facilities, and a stable supply chain to support their molecules at any scale from preclinical to commercial. In this interview with Outsourcing-Pharma, Dr. Youchu Wang, our SVP and Head of API Early Phase Development, discussed how WuXi STA aligns with global customers in response to the growing demand for complex conjugates to enable more possibilities for breakthroughs.
Menu
CONNECT WITH US
